Article

Endocrine Month in Review: February 2022

Editor's Note: Clicking in the center of a slide will redirect you to the affiliated article or video.

Related Videos
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
Should We Reclassify Diabetes Subtypes?
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Related Content
Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
October 21st 2024

Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

Victoria Johnson
Brian Hansen | Credit: Ascensia Diabetes Care
October 15th 2024

Diabetes Dialogue: What to Know About the Eversense 365 CGM, with Brian Hansen

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Pam Taub, MD | Credit: UC San Diego Health
October 8th 2024

Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial

Patrick Campbell
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
September 12th 2024

Diabetes Dialogue: Real-World Experience with the Dexcom Stelo

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA Decisions to Watch in Q4 2024 thumbnail
October 4th 2024

5 FDA Decisions to Watch in Q4 2024

Patrick Campbell
TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency| Image Credit: US Food and Drug Administration
September 30th 2024

TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.